Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-012429
Filing Date
2024-02-07
Accepted
2024-02-07 19:42:57
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 3/A ownership.html 3/A  
1 3/A ownership.xml 3/A 2639
  Complete submission text file 0000950170-24-012429.txt   4324
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kim Robert Young (Reporting) CIK: 0001971608 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39782 | Film No.: 24606421